See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

Presenter: Klaudija Bijuklic

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain)

Presenter: Issam Mikati

October 23, 2012

Presentation TCT 2012

Yukon (Translumina) Program Update

Presenter: Julinda Mehilli

October 23, 2012

Presentation TCT 2012

Radial Artery Hemostasis and Occlusion

Presenter: Samir Pancholy

October 23, 2012

Presentation TCT 2012

First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve)

Presenter: Stefan Verheye

October 23, 2012

Presentation TCT 2012

TCT-22. Combination of High Wall Shear Stress, Plaque Burden, and Plaque Phenotype has Incremental Value for Prediction of Increased Plaque Vulnerability in Patients with...

Presenter: Michel Corban

October 23, 2012

Presentation TCT 2012

TCT-72. Impact of Gender on Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: Pooled Analysis from the SPIRIT II, III and IV Trials

Presenter: Usman Baber

October 23, 2012

Presentation TCT 2012

New Insights into Normal and Diseased Mitral Valve Anatomy

Presenter: David Adams

October 23, 2012

Presentation TCT 2012

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(3)

Presenter: Ian Meredith

October 23, 2012

Advertisement

Slides

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain)

Yukon (Translumina) Program Update

Radial Artery Hemostasis and Occlusion

First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve)

TCT-22. Combination of High Wall Shear Stress, Plaque Burden, and Plaque Phenotype has Incremental Value for Prediction of Increased Plaque Vulnerability in Patients with...

TCT-72. Impact of Gender on Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: Pooled Analysis from the SPIRIT II, III and IV Trials

New Insights into Normal and Diseased Mitral Valve Anatomy

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(3)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content